Chaumont Agnes, Martin Alison, Flamaing Johan, Wiseman Dexter J, Vandermeulen Corinne, Jongert Erik, Doherty Timothy Mark, Buchy Philippe, Varga Steven M, Warter Lucile
GSK, Abbortsford, Australia.
Crystallise Ltd, Essex, UK.
Expert Rev Clin Immunol. 2025 Jun;21(6):745-760. doi: 10.1080/1744666X.2025.2494658. Epub 2025 May 2.
INTRODUCTION: Respiratory syncytial virus (RSV) is an important pathogen in infants, children, older adults, and those with comorbidities. Mechanisms involving viral proteins appear to underlie the ability of RSV to evade and modulate host immunity. We aimed to understand virus- and host-dependent factors regulating the development and severity of RSV infection, as related to the prevention and treatment of RSV-associated disease in adults, through a systematic literature review (SLR). METHODS: An SLR was conducted to identify immune mechanisms involved in the protective response to RSV infection in adults, and responses that may contribute to the development of severe disease. Concurrent searches (MEDLINE/Embase) using embase.com identified relevant papers published between 1990 and 19 April 2023. RESULTS: Of 1813 records identified, 113 were selected for review. Inclusion criteria were based on relevant patient populations, outcomes, and study methodologies. RSV is common, recurrent, and associated with high morbidity and mortality in older adults and people with underlying chronic diseases. Immune responses differ between younger and older adults. The approval of effective vaccines may protect older individuals from symptomatic RSV infection. CONCLUSIONS: We established the complexities of RSV immune response, but further research is required to fully understand anti-RSV immunology.
引言:呼吸道合胞病毒(RSV)是婴儿、儿童、老年人以及患有合并症者的重要病原体。涉及病毒蛋白的机制似乎是RSV逃避和调节宿主免疫能力的基础。我们旨在通过系统文献综述(SLR),了解与成人RSV相关疾病的预防和治疗相关的、调节RSV感染发展和严重程度的病毒和宿主依赖性因素。 方法:进行了一项系统文献综述,以确定成人对RSV感染的保护性反应中涉及的免疫机制,以及可能导致严重疾病发展的反应。使用embase.com进行的并行检索(MEDLINE/Embase)确定了1990年至2023年4月19日期间发表的相关论文。 结果:在识别出的1813条记录中,113条被选入综述。纳入标准基于相关患者群体、结局和研究方法。RSV在老年人和患有慢性基础疾病的人群中常见、易复发,且与高发病率和死亡率相关。年轻人和老年人的免疫反应有所不同。有效疫苗的获批可能会保护老年人免受有症状的RSV感染。 结论:我们确定了RSV免疫反应的复杂性,但需要进一步研究以全面了解抗RSV免疫学。
Cochrane Database Syst Rev. 2023-10-23
Cochrane Database Syst Rev. 2022-5-20
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2020-10-19